Skip to main content
ENGN logo

ENGN · enGene Therapeutics Inc. · Analyst Estimates

Track ENGN — free
$1.74 -0.02 (-1.14%) At close · Nov 20
Market Cap
$116.61M
Shares
67.02M
Volume · Nov 20 556.73K Avg daily vol (3M) 1.1M

Analyst Estimates

Compare analyst forecasts for enGene Therapeutics Inc. across metrics and forecast periods.

Estimates are grouped by forecast period, with low, average and high together. A dash means that statistic is not available.

Pull consensus estimates through the analyst estimates API or MCP →

Compiled consensus

These figures are a compiled consensus of analyst forecasts, not a survey the company published itself. Every figure is the statistic the source states; averages are means, never medians. An EPS figure names its accounting basis, GAAP or Non-GAAP, where the capture records one, and compares only with the company's EPS on that basis; without one, the basis is not recorded.

Captured 2026-11-14 05:29 UTC · Publication dates shown per estimate · 8 metric / period groups

FY ending 2026-10-31

Analyst estimates for FY ending 2026-10-31
Metric Low Average High Analyst count Average, 7 days ago Average, 30 days ago Average, 60 days ago Average, 90 days ago Estimates lowered, last 7 days Estimates lowered, last 30 days Estimates raised, last 7 days Estimates raised, last 30 days
EPS
USD
Publication date not stated
-1.89
-1.82
-1.73
8
-1.81
-1.81
-1.81
-1.73
6
6
2
2
Revenue
USD
Publication date not stated
0.00
0.00
0.00
8
— — — — — — — —

FY ending 2027-10-31

Analyst estimates for FY ending 2027-10-31
Metric Low Average High Analyst count Average, 7 days ago Average, 30 days ago Average, 60 days ago Average, 90 days ago Estimates lowered, last 7 days Estimates lowered, last 30 days Estimates raised, last 7 days Estimates raised, last 30 days
EPS
USD
Publication date not stated
-1.98
-1.59
-1.03
7
-1.51
-1.45
-1.44
-1.40
4
4
3
3
Revenue
USD
Publication date not stated
0.00
4.68M
14.67M
7
— — — — — — — —

Q ending 2026-10-31

Analyst estimates for Q ending 2026-10-31
Metric Low Average High Analyst count Average, 7 days ago Average, 30 days ago Average, 60 days ago Average, 90 days ago Estimates lowered, last 7 days Estimates lowered, last 30 days Estimates raised, last 7 days Estimates raised, last 30 days
EPS
USD
Publication date not stated
-0.55
-0.47
-0.39
8
-0.46
-0.46
-0.46
-0.41
5
5
2
2
Revenue
USD
Publication date not stated
0.00
0.00
0.00
8
— — — — — — — —

Q ending 2027-01-31

Analyst estimates for Q ending 2027-01-31
Metric Low Average High Analyst count Average, 7 days ago Average, 30 days ago Average, 60 days ago Average, 90 days ago Estimates lowered, last 7 days Estimates lowered, last 30 days Estimates raised, last 7 days Estimates raised, last 30 days
EPS
USD
Publication date not stated
-0.44
-0.38
-0.30
3
-0.34
-0.34
-0.34
-0.31
3
3
0
0
Revenue
USD
Publication date not stated
0.00
0.00
0.00
4
— — — — — — — —
Key facts CIK 1980845 CUSIP 29286X101 13F (30d) 59 filings 58 filers Visit website Investor relations